Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Wall Street is counting on bitcoin's high volatility for year-end bonuses
Wall Street is counting on bitcoin's high volatility for year-end bonuses

ETF has not "tamed" bitcoin; volatility remains the most attractive indicator of the asset.

Chaincatcher·2025/11/23 16:42
Nasdaq-listed Enlivex plans $212 million fundraise for Rain token treasury, calling it first prediction-markets DAT
Nasdaq-listed Enlivex plans $212 million fundraise for Rain token treasury, calling it first prediction-markets DAT

Quick Take Enlivex Therapeutics, a Nasdaq-listed biopharma company, plans a $212 million fundraise to build a Rain token digital asset treasury strategy. Matteo Renzi, former Prime Minister of Italy, will join the Enlivex board of directors following the closing of the fundraise, the company said.

The Block·2025/11/23 16:00
‘100% track record of coming back’: IBIT short interest sinks toward April lows as bitcoin bears unwind positions
‘100% track record of coming back’: IBIT short interest sinks toward April lows as bitcoin bears unwind positions

Quick Take Bitcoin ETF outflows are still heavy, but analysts say long-term holders are quietly accumulating while traders reset positions. Friday marked the first positive flow day for U.S. bitcoin ETPs in a week, hinting at early signs of stabilization.

The Block·2025/11/23 16:00
Grayscale rolls out XRP ETF, expanding its crypto fund lineup
Grayscale rolls out XRP ETF, expanding its crypto fund lineup

Quick Take The firm debuted its fund tracking the value of XRP with the ticker symbol GXRP on Monday. Grayscale follows other firms that have launched XRP ETFs, including Canary Capital and REX Shares.

The Block·2025/11/23 16:00
Monad mainnet launches with 50.6% of total MON token supply initially locked
Monad mainnet launches with 50.6% of total MON token supply initially locked

Quick Take Monad’s mainnet debut follows several weeks of MON token distribution efforts designed to foster ecosystem participation and co-ownership. According to the project’s tokenomics plan, 50.6% of the locked MON supply will gradually vest until the end of 2029.

The Block·2025/11/23 16:00
Trump Family Takes $1B Hit in Crypto Crash, Loses Spot in Bloomberg 500 Billionaire Index
Trump Family Takes $1B Hit in Crypto Crash, Loses Spot in Bloomberg 500 Billionaire Index

The Trump family fortune declined by approximately $1 billion in two months as cryptocurrency markets crashed, with Bitcoin falling from $125,000 to $82,000 amid market instability.

Coinspeaker·2025/11/23 16:00
Arthur Hayes Forecasts BTC Drop Below $80K Ahead of Fed QT Halt
Arthur Hayes Forecasts BTC Drop Below $80K Ahead of Fed QT Halt

Arthur Hayes predicts Bitcoin may dip below $80K before the Fed ends QT on Dec 1. Market liquidity shows early signs of improvement.

Coinspeaker·2025/11/23 16:00
Brevan Howard offered $25 million 'refund right' for its Berachain investment: Unchained
Brevan Howard offered $25 million 'refund right' for its Berachain investment: Unchained

Quick Take Brevan Howard’s 2024 investment in Berachain reportedly came with a refund stipulation active for one year following the BERA token launch, according to documents published by Unchained. The firm’s Nova Digital subsidiary co-led Berachain’s $69 million Series B funding round at a $1.5 billion valuation.

The Block·2025/11/23 16:00
Flash
20:57
US Dollar Index Falls 0.09% on 16th
The US Dollar Index fell 0.09% on the 16th, closing at 99.540 in the foreign exchange market.
20:48
According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a tiered royalty structure.
The document further clarifies the conditions and specific terms that trigger payment. Milestone payments will be distributed in phases based on the progress of R&D in the collaborative project, regulatory approvals, and commercialization outcomes at different stages. Tiered royalties mean that as product sales reach different thresholds, the rates will be adjusted accordingly, providing both parties with a more flexible revenue-sharing mechanism. This financial arrangement highlights both parties' confidence in the project's prospects and reflects the risk-sharing and profit-sharing models commonly seen in the biopharmaceutical industry. Although the details of the agreement have not been fully disclosed, the total potential revenue of up to $320 million undoubtedly injects strong financial momentum into the subsequent development of the project.
20:48
According to a filing submitted to the U.S. Securities and Exchange Commission, biotechnology company Arvinas Holding Company LLC, pharmaceutical giant Pfizer, and Rigel Pharmaceuticals obtained approval under the Hart–Scott–Rodino Antitrust Improvements Act on June 11, 2026.
This key development has removed regulatory obstacles for all parties to advance the previously announced licensing agreement. The conclusion of this agreement marks a new substantive phase in the related cooperation. Passing the HSR antitrust review is a crucial step in strategic collaborations involving intellectual property and market access. This usually means that regulatory authorities have determined the transaction will not materially harm competition in the relevant market. With this regulatory threshold crossed, all parties are expected to accelerate implementation of the detailed terms of the licensing agreement, boosting progress in related R&D or commercialization projects. This dynamic is being closely watched by industry observers.
News